Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunogen Inc
(NQ:
IMGN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunogen Inc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
These 8 Stocks Are Outperforming Nvidia In 2023
September 18, 2023
Carvana has surged 1,001%, leading huge winners this year.
Via
Investor's Business Daily
ImmunoGen Appoints Lauren White as Senior Vice President and Chief Financial Officer
September 18, 2023
From
ImmunoGen, Inc.
Via
Business Wire
Ovarian Cancer Player ImmunoGen Can Potentially Be Attractive M&A Target: JP Morgan
September 13, 2023
JP Morgan upgraded ImmunoGen Inc (NASDAQ: IMGN) from Neutral to Overweight with a price target of $22, up from $9, based on insights gathered from a recent physician survey, which focused on the...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 11, 2023
Via
Benzinga
10 Analysts Have This to Say About Immunogen
August 29, 2023
Via
Benzinga
Analyst Ratings for Immunogen
August 01, 2023
Via
Benzinga
BMO Capital Maintains Outperform Rating for Immunogen: Here's What You Need To Know
August 01, 2023
Via
Benzinga
Preview: Immunogen's Earnings
July 28, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2023
September 13, 2023
Via
Benzinga
7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth
September 07, 2023
Finding the best pharma stocks to buy takes a little effort, but it will pay of with these seven long-term winners.
Via
InvestorPlace
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 05, 2023
From
ImmunoGen, Inc.
Via
Business Wire
Verizon To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Tuesday
August 29, 2023
Stifel raised the price target for Hersha Hospitality Trust (NYSE: HT) from $8.75 to $10. Stifel analyst Simon Yarmak downgraded the stock from Buy to Hold. Hersha Hospitality Trust shares fell 0.5% to...
Via
Benzinga
ImmunoGen Inks Pact With Takeda To Develop ELAHERE Ovarian Cancer Drug In Japan
August 28, 2023
ImmunoGen, Inc. (NASDAQ: IMGN) inked pacts with Takeda Pharmaceutical Company Limited (NYSE: TAK) to develop and
Via
Benzinga
ImmunoGen Announces Collaboration with Takeda to Develop and Commercialize ELAHERE® in Japan
August 28, 2023
From
ImmunoGen, Inc.
Via
Business Wire
5 Meme Stocks to Sell Immediately, According to AI
August 22, 2023
As we move into September, the MarketMaster AI is flashing warning signals about risky equities. Sell these meme stocks right now.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
These Are the ONLY 3 Biotech Stocks to Consider in August 2023
August 21, 2023
These biotech stocks to buy represent tremendous bets and are essentially fueling innovation and portfolio growth at the same time.
Via
InvestorPlace
How To Invest In The Healthcare Sector
August 19, 2023
If things go wrong with some healthcare companies, investors often justify why they stay in the stock. And when things go right, they can go right in a hurry. Mersana Therapeutics is an example of how...
Via
Talk Markets
7 A-Rated Biotech Stocks for Your August Buy List
August 17, 2023
Investing in biotech stocks means accepting a long R&D window, but the rewards when your A-rated biotech stocks come through are huge.
Via
InvestorPlace
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2023
From
ImmunoGen, Inc.
Via
Business Wire
ImmunoGen Outperforms Q2 Revenue Expectations Bolstered By Strong Elahere Sales
July 31, 2023
ImmunoGen Inc (NASDAQ: IMGN) reported Q2 revenues of $83.15 million, surpassing the consensus of $42.84 million and
Via
Benzinga
Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 07, 2023
Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
July 31, 2023
It's time to start off the week with a breakdown of the biggest pre-market stock movers worth watching for Monday morning!
Via
InvestorPlace
ImmunoGen Announces Departure of Anna Berkenblit, Chief Medical Officer
July 31, 2023
From
ImmunoGen, Inc.
Via
Business Wire
ImmunoGen Reports Recent Progress and Second Quarter 2023 Financial Results
July 31, 2023
From
ImmunoGen, Inc.
Via
Business Wire
ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Canaccord Genuity 43rd Annual Growth Conference
July 27, 2023
From
ImmunoGen, Inc.
Via
Business Wire
Earnings Scheduled For July 31, 2023
July 31, 2023
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million.
Via
Benzinga
ImmunoGen Announces Multi-Target License and Option Agreement with ImmunoBiochem to Develop Next-Generation Antibody-Drug Conjugates
July 24, 2023
From
ImmunoGen, Inc.
Via
Business Wire
ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2023 Operating Results
July 17, 2023
From
ImmunoGen Inc.
Via
Business Wire
Viasat, MillerKnoll And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
July 13, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
3 Biotech Stocks to Make Your ‘Get Rich’ Dreams Come True
July 06, 2023
These high return biotech stocks offer tremendous upside ahead and are likely to soar on the back of several growth drivers
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.